Information Journal Paper
APA:
Copy. (2020). Epigenetics and prostate cancer: defining the timing of DNA methyltransferase deregulation during prostate cancer progression. PATHOLOGY, 52(2), 218-227. SID. https://sid.ir/paper/971694/en
Vancouver:
Copy. Epigenetics and prostate cancer: defining the timing of DNA methyltransferase deregulation during prostate cancer progression. PATHOLOGY[Internet]. 2020;52(2):218-227. Available from: https://sid.ir/paper/971694/en
IEEE:
Copy, “Epigenetics and prostate cancer: defining the timing of DNA methyltransferase deregulation during prostate cancer progression,” PATHOLOGY, vol. 52, no. 2, pp. 218–227, 2020, [Online]. Available: https://sid.ir/paper/971694/en